Cargando…
Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment in COVID-19
At present, there is no vaccine or effective standard treatment for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection (or coronavirus disease-19 (COVID-19)), which frequently leads to lethal pulmonary inflammatory responses. COVID-19 pathology is characterized by extreme inflamm...
Autores principales: | Orienti, Isabella, Gentilomi, Giovanna Angela, Farruggia, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312074/ https://www.ncbi.nlm.nih.gov/pubmed/32471278 http://dx.doi.org/10.3390/ijms21113812 |
Ejemplares similares
-
Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor
por: Orienti, Isabella, et al.
Publicado: (2020) -
A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model
por: Orienti, Isabella, et al.
Publicado: (2019) -
Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule
por: Potenza, Rosa Luisa, et al.
Publicado: (2022) -
Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model
por: Durante, Sandra, et al.
Publicado: (2014) -
Nanospermidine in Combination with Nanofenretinide Induces Cell Death in Neuroblastoma Cell Lines
por: Lodeserto, Pietro, et al.
Publicado: (2022)